Skip to content
drillr.ai
Sign up

ALLO

Allogene Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.97
−0.51%
Ask drillr
0
Insider buys (3m)
1
Insider sells (3m)
-$63.0K
Net value (3m)
+5.9%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 25, 2026Douglas Earl Martin · officer: SVP, General CounselSale29,697$2.12
Jul 6, 2026Roberts Zachary · officer: President and CEOA-Award476,190$2.11
Jul 6, 2026Roberts Zachary · officer: President and CEOA-Award134,530$0.00
Jun 23, 2026Barrett Elizabeth A. · directorA-Award95,400$0.00
Jun 23, 2026Humer Franz B · directorA-Award95,400$0.00
Jun 23, 2026WITTE OWEN N. · directorA-Award95,400$0.00
Jun 23, 2026SATO VICKI L · directorA-Award95,400$0.00
Jun 23, 2026Mayo Stephen · directorA-Award144,400$2.00
Jun 23, 2026MESSEMER DEBORAH M. · directorA-Award95,400$0.00
Jun 23, 2026Kazam Joshua A · directorA-Award95,400$0.00
Jun 23, 2026Kazam Joshua A · directorM-Exempt47,700$0.00
Apr 23, 2026Yoshiyama Annie · officer: SVP, FinanceSale9,586$2.31
Apr 2, 2026Beneski Benjamin Machinas · officer: SVP, Chief Technical OfficerSale2,867$2.50
Mar 18, 2026Chang David D · director, officer: President and CEOSale47,763$2.47
Mar 18, 2026Beneski Benjamin Machinas · officer: SVP, Chief Technical OfficerSale4,835$2.47
Mar 4, 2026Beneski Benjamin Machinas · officer: SVP, Chief Technical OfficerSale7,132$2.60
Feb 4, 2026Roberts Zachary · officer: EVP of R&DA-Award203,307$0.00
Feb 4, 2026Belldegrun Arie · directorA-Award929,913$1.87
Feb 4, 2026Belldegrun Arie · directorA-Award263,033$0.00
Feb 4, 2026Yoshiyama Annie · officer: SVP, FinanceSale4,167$1.72
Feb 4, 2026Beneski Benjamin Machinas · officer: SVP, Chief Technical OfficerA-Award373,757$1.87
Feb 4, 2026Beneski Benjamin Machinas · officer: SVP, Chief Technical OfficerSale7,549$1.73
Feb 4, 2026Chang David D · director, officer: President and CEOSale95,269$1.80
Feb 4, 2026Chang David D · director, officer: President and CEOA-Award1,387,931$1.87
Feb 4, 2026Chang David D · director, officer: President and CEOA-Award392,586$0.00
Feb 4, 2026Parker Geoffrey M. · officer: CHIEF FINANCIAL OFFICERSale24,001$1.76
Feb 4, 2026Parker Geoffrey M. · officer: CHIEF FINANCIAL OFFICERA-Award539,072$1.87
Feb 4, 2026Parker Geoffrey M. · officer: CHIEF FINANCIAL OFFICERA-Award152,480$0.00
Feb 4, 2026Douglas Earl Martin · officer: SVP, General CounselSale22,900$1.76
Feb 4, 2026Douglas Earl Martin · officer: SVP, General CounselA-Award539,072$1.87
Institutional positioning

13F filings over the trailing two quarters

New 82Increased 176Reduced 98Sold out 28
FilerActionSharesFiled
BlackRock, Inc.Increased30,146,963Aug 7, 2026
Frazier Life Sciences Management, L.P.Increased22,446,668Aug 14, 2026
PFIZER INCUnchanged22,032,040May 12, 2026
PFIZER INCUnchanged22,032,040Aug 13, 2026
BLACKROCK, INC.Increased19,091,095May 13, 2026
STATE STREET CORPIncreased19,025,826Aug 7, 2026
TPG GP A, LLCUnchanged18,716,306Aug 14, 2026
TPG GP A, LLCUnchanged18,716,306May 15, 2026
Sio Capital Management, LLCNew Position13,323,431Aug 14, 2026
PRIMECAP MANAGEMENT CO/CA/Increased13,123,440Aug 14, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased12,166,636Aug 13, 2026
FMR LLCIncreased12,009,043Aug 13, 2026
CITADEL ADVISORS LLCIncreased10,223,370Sep 2, 2026
STATE STREET CORPIncreased8,660,306May 15, 2026
PRIMECAP MANAGEMENT CO/CA/Increased8,379,840May 11, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 25, 2026